Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study. Perez de Isla L, Diaz-Diaz JL, Romero MJ, Muniz-Grijalvo O, et al. Circulation 2023 Apr 3. doi: 10.1161/CIRCULATIONAHA.122.062557.

Read + Share

Amedeo Smart

Independent Medical Education

Perez de Isla L, Diaz-Diaz JL, Romero MJ, Muniz-Grijalvo O, et al. Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study. Circulation 2023 Apr 3. doi: 10.1161/CIRCULATIONAHA.122.062557.
PMID: 37009731